Micro-scale surgery that lowers eye pressure through the same incision used for cataract removal.
MIGS procedures use microscopic implants and ab-interno incisions to lower intraocular pressure with far less tissue disruption than traditional glaucoma surgery. They are most often performed alongside cataract surgery, treating two conditions through a single incision. For mild to moderate glaucoma, MIGS offers a meaningful drop in pressure — and often a meaningful drop in the number of daily medications.
Free, no-obligation — you pay the hospital directly with no markup.
MIGS encompasses a group of procedures that work from inside the eye to improve aqueous outflow. Unlike trabeculectomy, which creates a new drainage channel through the eye wall, MIGS devices bypass the point of highest outflow resistance — the trabecular meshwork — or create a controlled route to the subconjunctival space, depending on the device.
The defining advantage is the safety profile. Complication rates are substantially lower than with filtering surgery, recovery is measured in days rather than weeks, and the procedure preserves conjunctival tissue for future interventions if they become necessary. The trade-off is a more modest pressure reduction, which is why MIGS is generally reserved for mild to moderate disease.
MIGS is a short procedure, but the device selection and surgical execution still matter. Thailand's glaucoma centres offer the full range of approved devices and the subspecialist expertise to match the right one to your anatomy.
Subspecialist
Fellowship-Trained Surgeons
Our partner glaucoma surgeons implant the full range of MIGS devices regularly — iStent, Hydrus, and XEN — with the case volume that builds confident device selection.
40–60%
Significant Cost Savings
MIGS in Thailand costs 40–60% less than equivalent procedures at home. Device costs are comparable globally — the savings come from lower surgical and facility fees.
Days
Rapid Scheduling
No waiting lists. Assessment, surgery, and post-operative checks are completed within your 5–7 day stay. Combined cataract-MIGS cases follow the same efficient timeline.
Combined
Cataract and Glaucoma Together
Combining MIGS with cataract surgery through a single incision addresses both conditions in one session — practical for international patients and a core strength of our partner centres.
We do not charge for our service — you pay the hospital directly with no markup. MIGS device costs are comparable globally; the savings in Thailand come from lower surgical and facility fees.
Your Quote Will Include
Prices are approximate and vary by technique, surgeon, and hospital. Your personalised quote will include a full cost breakdown.
MIGS in Thailand typically costs between $3,500 and $6,300. The range depends on the device used, whether the procedure is standalone or combined with cataract surgery, and the hospital. Trabecular micro-bypass devices generally sit at the lower end; XEN gel stent procedures cost more due to greater surgical complexity.
The total covers the glaucoma surgeon's fee, the MIGS device itself, anaesthesia, operating theatre, post-operative medications and drops, and all follow-up appointments during your stay. For combined cataract-MIGS cases, the intraocular lens is included in the cataract component of the quote.
Device choice is the biggest variable. iStent and Hydrus procedures are shorter and less complex than XEN implantation. Standalone MIGS costs more than combined cataract-MIGS because the infrastructure for the corneal incision is already in place during phacoemulsification. Bilateral procedures are typically quoted at a package rate.
Pricing varies by the complexity and scope of the procedure. Typical ranges at our partner hospitals in Thailand:
Exact pricing is confirmed after your consultation and treatment plan are finalised.
MIGS in Thailand costs 40–60% less than in the US ($8,800–$14,000), Australia (A$8,000–A$13,300), and UK (£7,000–£12,300). Device costs are essentially the same everywhere — the difference sits in surgical fees, anaesthesia, and hospital charges at JCI-accredited Thai centres.
Several device categories exist, each targeting a different part of the drainage system. The choice depends on your angle anatomy, pressure target, and whether cataract surgery is planned at the same time.
Tiny stents inserted into the trabecular meshwork bypass the primary outflow resistance. The iStent inject places two micro-stents via a single injector; the Hydrus scaffolds open a wider arc of Schlemm's canal. Both are implanted through the cataract incision.
A flexible gelatin stent placed ab interno drains aqueous from the anterior chamber to the subconjunctival space — mechanically similar to trabeculectomy but without a scleral flap. It achieves lower pressures than trabecular devices and can be performed standalone.
The technical approach depends on the device selected. All MIGS procedures share the ab-interno philosophy — working from inside the eye through a small corneal incision — but the drainage target and mechanism differ.
A suture or microcatheter is threaded through Schlemm's canal for 360 degrees and pulled through, opening the trabecular meshwork along its full circumference. No implant is left behind. Achieves greater pressure reduction than single-stent devices.
A laser probe inserted through the cataract incision directly treats the ciliary processes, reducing aqueous production. Often combined with cataract surgery. Particularly useful when the drainage angle is not suitable for stent placement.
Mild irritation, redness, and slightly hazy vision are common. Antibiotic and anti-inflammatory drops start immediately. Most patients resume light activity the same day. A pressure check is performed within 24 hours to confirm the device is functioning.
Vision clears steadily — often faster than patients expect. Drop regimen continues as directed. Device position and pressure are confirmed at your follow-up before travel. Avoid rubbing the eye, heavy lifting, and swimming.
Steroid drops are tapered on a set schedule. Glaucoma medications may be reduced based on pressure response. Most patients are back to all normal activities within the first week or two.
The full benefit of the MIGS device becomes apparent as pressure stabilises at its new baseline. Your glaucoma specialist at home adjusts medications accordingly. Most patients achieve a clinically meaningful reduction in daily drops.
Most patients can fly home within 5–7 days. MIGS recovery is fast — once your surgeon confirms stable pressure and satisfactory healing at the post-operative check, flying is safe. Continue your prescribed drops during travel and arrange follow-up with your glaucoma specialist at home within a few weeks.
Light daily activity resumes from day one. Desk work and screen use are fine within the first few days. Avoid heavy lifting, swimming, and dusty environments for the first two weeks. Strenuous exercise can resume once your surgeon confirms everything is stable at your follow-up.
Pressure reduction begins immediately, but the full effect takes 1–3 months to stabilise — particularly for XEN stents, where the subconjunctival bleb matures over several weeks. Your home glaucoma specialist monitors pressure and adjusts medications based on the sustained response.
MIGS procedures carry the lowest complication rate of any surgical glaucoma intervention. That safety advantage is the primary reason they were developed.
The overall complication profile is substantially better than trabeculectomy or tube shunt surgery. Each device carries its own specific risk profile, which is covered in detail at your consultation along with what to watch for during recovery.
Yes. Our partner hospitals hold JCI accreditation and stock the same FDA-approved devices used at leading centres in the US, Europe, and Australia. Surgeons are fellowship-trained glaucoma subspecialists who implant these devices as a routine part of their practice. Published safety outcomes for MIGS at accredited Thai centres are consistent with international data.
Device selection is the most important factor. An experienced glaucoma surgeon matches the device to your angle anatomy, pressure target, and disease stage. Trabecular devices are safest but offer less pressure reduction. XEN stents offer more reduction but require bleb management. Getting this decision right is where subspecialist judgment matters.
One of the strengths of MIGS is that it preserves your options. The procedure does not disrupt conjunctival tissue the way trabeculectomy does, so if additional pressure lowering is needed in future, medications, laser, or traditional filtering surgery remain available. Insufficient response is managed — not a dead end.
MIGS device selection requires glaucoma subspecialist judgment. Here is what matters when choosing where to have it done.
Our partner hospitals have dedicated glaucoma departments equipped with gonioscopy suites, anterior segment OCT, visual field analysers, and the full range of approved MIGS devices. They perform combined cataract-MIGS procedures daily — it is core work, not occasional.
Our partner surgeons completed glaucoma fellowships and implant MIGS devices as a standard part of their surgical practice. They select between trabecular, subconjunctival, and angle-based approaches based on anatomy and disease stage — not just defaulting to whichever device they have available.
Ask which devices they routinely use and why they would recommend one over another for your case. A surgeon who only implants one type of device may not be the best fit. Also ask about their combined cataract-MIGS volume and their approach to XEN bleb management if that device is being considered.
MIGS does not restore vision — it lowers the pressure that damages the optic nerve. The benefit is measured in pressure numbers and medication reduction, not visual acuity.
Trabecular micro-bypass devices typically reduce IOP by 20–30% and allow one or more drops to be discontinued. XEN gel stents achieve greater reductions, closer to what trabeculectomy delivers. Studies show sustained pressure control at three to five years for both device categories. The degree of benefit depends on where you start and which device is used.
Your surgeon sets a target pressure based on the stage of your glaucoma and the extent of optic nerve damage. MIGS may meet that target entirely or may get you close enough that a single drop covers the remaining gap. The consultation is where you find out what is realistically achievable with your anatomy and disease stage.
MIGS requires one of the shortest stays of any procedure we coordinate — 5–7 days covers everything.
Plan for 5–7 days. Day one covers your pre-operative assessment and gonioscopy. Surgery is typically scheduled within 1–2 days. Post-operative checks confirm device position and pressure before you fly home. Combined cataract-MIGS cases follow the same timeline.
Your care coordinator handles hospital scheduling, transfers, and all follow-up appointments. The surgical quote includes the surgeon's fee, MIGS device, anaesthesia, facility charges, post-operative drops, and a detailed handover report for your home glaucoma specialist.
Before departure, your surgical team prepares a comprehensive report covering device type and position, current IOP, medication schedule, and recommended follow-up intervals. This is shared directly with your home glaucoma specialist. Ongoing pressure monitoring at home is essential — MIGS is the start of better control, not the end of all management.
Your MIGS surgery questions answered
Patient Care Director
Last reviewed: March 25, 2026
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice. Individual results, recovery times, and suitability vary. Always consult a qualified ophthalmologist before making decisions about treatment.
Speak with our care coordinators to discuss your glaucoma and find out whether MIGS could reduce your reliance on daily eye drops.
Speak to Our TeamTestimonials
From LASIK to retinal repair, patients share why they chose Thailand.
Free Service
Share your eye concern and we'll recommend the right specialist, hospital, and treatment path within 24 hours.
Get in Touch
Tell us about your eye condition and our care team will get back to you within 24 hours.
Loading your quote form...